An Australian-first COVID-19 vaccine effectiveness study has shown that receipt of a booster (third) COVID-19 vaccine dose provided 65% greater protection against hospitalisation or death from Omicron than two vaccine doses. The NCIRS study followed over 2 million adults aged 40 years and over living in Greater Sydney during the peak of the Omicron wave in Australia in January and February 2022 for SARS-CoV-2 infection, hospitalisation and death.
Monkeypox (MPX) resources
A series of Monkeypox resources can be accessed on the Department of Health website. These resources provide information about the symptoms of MPX, preventing infection, as well as ATAGI clinical guidance on vaccination and treatment guidelines.
Novavax as a booster dose
Novavax is currently registered for use in a primary COVID-19 vaccination course in people aged 18 years or older. On 9 June 2022, the TGA provisionally approved the Novavax vaccine for use in Australia as a booster dose. ATAGI recommendations consider Novavax to be acceptable for use as a booster dose in an individual aged 18 or older if no other COVID-19 vaccine is suitable for that individual. ATAGI is currently reviewing available evidence and will update its recommendations regarding Novavax use as a booster shortly.
‘Kids will be kids’ COVID-19 vaccine campaign
On 24 June, the latest phase of the COVID-19 campaign was launched to encourage parents of children aged 5 to 15 to book their child’s COVID-19 vaccination. The ‘Kids will be kids’ campaign highlights the benefits of getting a COVID-19 vaccination to protect children against COVID-19. View the campaign materials.
‘Take on winter’ COVID-19 and flu vaccine campaign
On 23 June, the latest phase of the COVID-19 campaign was launched to encourage Australians to get up to date with their COVID-19 vaccination and receive their flu vaccination this winter. The new ‘Take on winter’ campaign reminds people we are more vulnerable to illnesses this year and it’s safe to have both COVID-19 and influenza vaccinations at the same time. View the campaign materials.
Winter is a very busy time for all immunisation providers, with the 2022 Influenza program coinciding with the continuing COVID-19 vaccine program. To avoid vaccine administration errors, providers should always check the vial and syringe to ensure the correct vaccine is being used, and confirm with patient prior to each administration. Providers can contact the VOC on 1800 318 208 for advice on vaccine administration errors that have occurred.
The ATAGI flowchart has been developed to help avoid vaccine administration errors. The flowchart summarises recommendations on suitable vaccine brands by age, booster eligibility, and appropriate dose intervals. It includes recommendations for both general population and special population groups (immunocompromised, pregnant, etc).
Opportunistic vaccination against flu and COVID-19
Although providers are encouraged to minimise waste, the DOH have recently announced that providers can now open a COVID-19 vial to opportunistically vaccinate a patient if required. Both the COVID-19 vaccine and the flu vaccine should be offered opportunistically to all patients during GP consultations, noting that COVID-19 and flu vaccines can be co-administered.
Upcoming immunisation webinars
Vaccine Acceptance in General Practice
This webinar will take a case-based approach to address low vaccine confidence and provide strategies to identify and engage patients who refuse vaccines.
Welcome to our new website! As you may have noticed, our website looks different. Central and Eastern Sydney PHN have moved to a new site and although much has remained the same, we have introduced some new functions. These include: Updated navigation When you land on our new website, you…
COVID-19 weekly update – 02 JANUARY 2023 COVID-19 cases in the region Please note: From next week the latest COVID-19 information will be included in the Sydney Health Weekly newsletter, rather than separated at the top. We will still provide COVID-19 related information as well as the dedicated COVID-19 latest…
FIVE QUESTIONS is where we ask members of the community to talk about how they stay HEALTHY. Randwick scientist and grandmother Hilda Stender shared this: What exercise did you do yesterday? I’ve had two knee replacements – one four years ago and the other six months ago. As a result,…
Immunisation weekly update – 1 February 2023 Childhood immunisation overdue reports CESPHN is inviting general practices to sign up to receive a regular report extracted on your behalf from the Australian Immunisation Register (AIR) which is specific to your practice. This report contains all children aged 0-5 living in the CESPHN region…
Australian Digital Health Agency (ADHA) digital health webinars Implementing MyHealth Record Policies in your organisation Thu 9 Feb 23, 12.30-1.00 pm – learn how to implement and maintain a My Health Record Security and Access policy in your organisation. Understand the importance of the Responsible Officer (RO) and Organisational Maintenance…
UNSW research – Palliative care and intellectual disability A research team led by Professor Julian Trollor at the Department of Developmental Disability Neuropsychiatry, UNSW Sydney, aims to design, implement, and evaluate a new palliative care service for people with intellectual disability. This is important because people with intellectual disability often…
GP support needed: Shared e-Care plan study for follow-up of colorectal and breast cancers This research evaluates shared care using a new interactive e-care plan being implemented through cancer services in Prince of Wales and St George public and private hospitals. Through the e-care plan GPs, cancer specialists and patients…